PIERIS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Outstanding from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Pieris Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2013 to Q2 2024.
  • Pieris Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 1.32M shares, a 98.7% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.32M -97.5M -98.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 1.24M -73.3M -98.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.24M -73.3M -98.3% Dec 31, 2023 10-Q 2024-08-14
Q2 2023 98.9M +24.6M +33.1% Jun 30, 2023 10-Q 2023-11-14
Q1 2023 74.5M +421K +0.57% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 74.5M +2.3M +3.18% Dec 31, 2022 10-K 2024-03-29
Q3 2022 74.4M +2.9M +4.06% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 74.3M +7.58M +11.4% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 74.1M +14.4M +24.1% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 72.2M +16.2M +29% Dec 31, 2021 10-K 2023-03-31
Q3 2021 71.5M +15.5M +27.8% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 66.7M +14.3M +27.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 59.7M +4.51M +8.16% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 56M +790K +1.43% Dec 31, 2020 10-K 2022-03-02
Q3 2020 56M +6.58M +13.3% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 52.4M +3.14M +6.37% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 55.2M +6.06M +12.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 55.2M +1.06M +1.96% Dec 31, 2019 10-K 2021-03-31
Q3 2019 49.4M -4.76M -8.79% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 49.3M -4.75M -8.79% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 49.2M -4.82M -8.94% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 54.2M +9.13M +20.3% Dec 31, 2018 10-K 2020-03-13
Q3 2018 54.1M +9.44M +21.1% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 54M +10.2M +23.2% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 54M +10.9M +25.4% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 45M +1.96M +4.55% Dec 31, 2017 10-K 2019-03-18
Q3 2017 44.7M +1.65M +3.82% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 43.8M +782K +1.82% Jun 30, 2017 10-Q 2017-08-11
Q1 2017 43.1M +3.23M +8.1% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 43.1M +3.23M +8.1% Dec 31, 2016 10-K 2018-03-15
Q3 2016 43.1M +3.3M +8.3% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 43.1M +13.6M +46.3% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 39.8M +10.4M +35.4% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 39.8M +10.6M +36% Dec 31, 2015 10-K 2017-03-30
Q3 2015 39.8M +33.7M +552% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 29.4M +23.3M +382% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 29.4M +24.4M +489% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 29.3M +17.5M +148% Dec 31, 2014 10-K 2016-03-23
Q3 2014 6.1M Sep 30, 2014 10-Q/A 2014-12-12
Q2 2014 6.1M +1.1M +22% Jun 30, 2014 10-Q/A 2014-12-12
Q1 2014 5M Mar 31, 2014 10-Q 2014-06-02
Q4 2013 11.8M Dec 31, 2013 10-K 2015-03-30
Q2 2013 5M Jun 30, 2013 10-K 2014-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.